Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis ; volume:20 ; number:1 ; day:16 ; month:7 ; year:2020 ; pages:1-15 ; date:12.2020
BMC neurology ; 20, Heft 1 (16.7.2020), 1-15, 12.2020
- Creator
-
Nicholas, Jacqueline A.
Edwards, Natalie C.
Edwards, Roger A.
Dellarole, Anna
Grosso, Megan
Phillips, Amy L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12883-020-01830-0
- URN
-
urn:nbn:de:101:1-2020091223230195870874
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nicholas, Jacqueline A.
- Edwards, Natalie C.
- Edwards, Roger A.
- Dellarole, Anna
- Grosso, Megan
- Phillips, Amy L.
- SpringerLink (Online service)
Other Objects (12)
Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
Current Disease-Modifying Therapies in Multiple Sclerosis
Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications
Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review
Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies
Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies
Disease-modifying treatments in Alzheimer’s disease
Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
Current Disease-Modifying Therapies in Multiple Sclerosis
Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications
Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review
Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies
Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies
Disease-modifying treatments in Alzheimer’s disease
Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
Current Disease-Modifying Therapies in Multiple Sclerosis
Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications
Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review
Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies
Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies